New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Users of GLP-1 drugs in the US cut their grocery spending by an average of 5.5% in the six months after taking the medication, a study shows.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts weigh the pros and cons of the practice.

In this review, we go over what HealthyWage is, how it works, and how you get paid. If your health is a focus this year, this ...

Americans are getting slimmer. The rise of GLP-1 medications has transformed the way Americans lose weight, and the data supports that: ...

Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person's chance ...

Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...

Wegovy doses go up higher, up to 2.4 milligrams weekly, versus 2 milligrams maximum for Ozempic. It’s not unusual for doctors to prescribe Ozempic off-label for weight loss, Hurtado Andrade says.